{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:01:49Z","timestamp":1768402909257,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T00:00:00Z","timestamp":1554508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.alit.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T01:31:21Z","timestamp":1556069481000},"page":"536-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5R\u03b1 antibody and TNF\u03b1 inhibitor"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5489-2062","authenticated-orcid":false,"given":"Hideyasu","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kurashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2019.04.003_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2019.04.003_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1381612805666230111210207","article-title":"Treating asthma with anti-IgE or anti-IL5","volume":"5","author":"L\u00f6tvall","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.alit.2019.04.003_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaip.2017.06.022","article-title":"Association of asthma with rheumatoid arthritis: a population-based case-control study","volume":"6","author":"Sheen","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2019.04.003_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090298","article-title":"Tumour necrosis factor-\u03b1 regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-\u03baB and AP-1","volume":"9","author":"Kankaanranta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2019.04.003_bib5","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1517\/13543780903136716","article-title":"Golimumab for severe asthma","volume":"18","author":"Antoniu","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.alit.2019.04.003_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","article-title":"A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma","volume":"179","author":"Wenzel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2019.04.003_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor alpha in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2019.04.003_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/thx.2007.086314","article-title":"The role of a soluble TNF\u03b1 receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo-controlled trial","volume":"63","author":"Morjaria","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.alit.2019.04.003_bib9","first-page":"539","article-title":"Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein","volume":"59","author":"H\u00e4llgren","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.alit.2019.04.003_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000070","article-title":"Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort","volume":"1","author":"Guellec","year":"2015","journal-title":"RMD Open"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:09:21Z","timestamp":1761156561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893019300498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1323893019300498"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2019.04.003","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5R\u03b1 antibody and TNF\u03b1 inhibitor","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}